DOI QR코드

DOI QR Code

생산공정이용 LMO 국내·외 안전관리제도 및 현황

The Status of Biosafety Management and Control for industrial Contained use of LMOs

  • 문건하 (한국생명공학연구원 바이오안전성정보센터)
  • Moon, Geon Ha (Korea Biosafety Clearing House, Korea Research Institute of Bioscience and Biotechnology)
  • 발행 : 2019.06.30

초록

"Contained use" means using LMOs during manufacturing processes within a facility, equipment or other physical structures to prevent the spread of LMOs to the external environment. LMOs and their substances not only have played an essential role in various industries in different ways, but also have made to spread concerns in Biosafety widely. In Korea, the LMO Act is to implement the Cartagena Protocol on Biosafety' since 1st Jan 2008. This is focused on Biosafety and Risk management for LMOs according to the precautionary principle.

키워드

참고문헌

  1. Jung-Il Cho, Gang-Seob Lee, Soo-Chul Park Global status of GM crop development and commercialization. J Plant Biotechnol. 43:147150 (2016)
  2. 한국바이오안전성정보센터, 바이오안전성의정서해설서. http://www.biosafety.or.kr/sub/info.do?m=020203&s=kbch#02, Accessed Jun 10, 2019
  3. 한국바이오안전성정보센터, 바이오안전성백서 http://www.biosafety.or.kr/sub/info.do?m=020205&s=kbch, Accessed Jun 10,2019
  4. 보건복지부. 유전자재조합실험지침 (2017)
  5. 식품안전정보원. https://www.foodsafetykorea.go.kr/portal/board/boardDetail.do, Accessed Jun 10, 2019
  6. 산업통상자원부, '제3차 유전자변형생물체 안전관리계획(2018-2022)' (2018)
  7. 한국바이오안전성정보센터. 생산공정이용 산업용 유전자변형생물체 위해성 평가기준 개발연구 (2017)
  8. 한국바이오안전성정보센터. 산업용 생산공정이용 유전자변형생물체 안전관리지침 개발연구 (2018)
  9. 経濟産業省. 遺伝子組み換え生物等の使用等 規制による生物多樣性の確保に に關する法律(カルタヘナ法) (2018)
  10. 한국바이오안전성정보센터. 국가별 바이오안전성 동향 (2018)